Evidence map›Paper›PMID 37689724›Full record

ArticlePilot and feasibility studies2023

Assessing the feasibility, acceptability, and fidelity of a tele-retinopathy-based intervention to encourage greater attendance to diabetic retinopathy screening in immigrants living with diabetes from China and African-Caribbean countries in Ottawa, Canada: a protocol.

Valerie Umaefulam, Mackenzie Wilson, Marie Carole Boucher, Michael H Brent, Maman Joyce Dogba, Olivia Drescher, Jeremy M Grimshaw, Noah M Ivers, John G Lawrenson, Fabiana Lorencatto and 23 more

Open access · goldAbstract read
In one paragraph

Article in Pilot and feasibility studies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 12 institutions in 3 countries.

Valerie UmaefulamClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Mackenzie WilsonClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Marie Carole BoucherDepartment of Ophthalmology, Maisonneuve-Rosemont Ophthalmology University Center, Université de Montréal, Montreal, QC, Canada.
Michael H BrentDepartment of Ophthalmology and Vision Sciences, Donald K Johnson Eye Institute, University Health Network, University of Toronto, Toronto, Canada.
Maman Joyce DogbaDepartment of Family and Emergency Medicine, Université Laval, Québec City, Canada.
Olivia DrescherDepartment of Family and Emergency Medicine, Université Laval, Québec City, Canada.
Jeremy M GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Noah M IversWomen's College Research Institute, Women's College Hospital, Toronto, Canada.
John G LawrensonSchool of Health & Psychological Sciences, City, University of London, London, UK.
Fabiana LorencattoCentre for Behaviour Change, University College London, London, UK.
David MaberleyDepartment of Ophthalmology, The Ottawa Hospital, Ottawa, Canada.
Nicola McClearyClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Sheena McHughSchool of Public Health, University College Cork, Cork, Ireland.
Olivera SutakovicDepartment of Ophthalmology and Vision Sciences, Donald K Johnson Eye Institute, University Health Network, University of Toronto, Toronto, Canada.
Kednapa ThavornClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Holly O WittemanDepartment of Family and Emergency Medicine, Université Laval, Québec City, Canada.
Catherine YuDivision of Endocrinology & Metabolism, St. Michael's Hospital, Faculty of Medicine, University of Toronto, Toronto, Canada.
Hao ChengPatient Local Advisory Group, Ottawa, Canada.
Wei HanPatient Local Advisory Group, Ottawa, Canada.
Yu HongPatient Local Advisory Group, Ottawa, Canada.
Balkissa IdrissaPatient Local Advisory Group, Ottawa, Canada.
Tina LeechCentretown Community Health Centre, Ottawa, Canada.
Joffré MaletteCentretown Community Health Centre, Ottawa, Canada.
Isabelle MongeonCentretown Community Health Centre, Ottawa, Canada.
Zawadi MugishoPatient Local Advisory Group, Ottawa, Canada.
Marlyse Mbakop NguebouDepartment of Family and Emergency Medicine, Université Laval, Québec City, Canada.
Sara PablaCentretown Community Health Centre, Ottawa, Canada.
Siffan RahmanCentretown Community Health Centre, Ottawa, Canada.
Azaratou SamandoulougouPatient Local Advisory Group, Ottawa, Canada.
Hasina VisramWest Ottawa Specialty Care, Ottawa, Canada.
Richard YouPatient Local Advisory Group, Ottawa, Canada.
Junqiang ZhaoSchool of Nursing, University of Ottawa, Ottawa, Canada.
Justin PresseauClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. jpresseau@ohri.ca.ORCID http://orcid.org/0000-0002-2132-0703
Regent Park Community Health Centre · CAUniversity of Ottawa · CAUniversité Laval · CAOttawa Hospital · CAUniversity Health Network · CACARE Canada · CACity, University of London · GBHôpital Maisonneuve-Rosemont · CASt. Michael's Hospital · CAUniversity College Cork · IEUniversity College London · GBUniversity of Toronto · CA

Funding

CIHR PJT-173245
6 · The paper itself

Abstract

backgroundDiabetic retinopathy is a leading cause of preventable blindness in Canada. Clinical guidelines recommend annual diabetic retinopathy screening for people living with diabetes to reduce the risk and progression of vision loss. However, many Canadians with diabetes do not attend screening. Screening rates are even lower in immigrants to Canada including people from China, Africa, and the Caribbean, and these groups are also at higher risk of developing diabetes complications. We aim to assess the feasibility, acceptability, and fidelity of a co-developed, linguistically and culturally tailored tele-retinopathy screening intervention for Mandarin-speaking immigrants from China and French-speaking immigrants from African-Caribbean countries living with diabetes in Ottawa, Canada, and identify how many from each population group attend screening during the pilot period.

methodsWe will work with our health system and patient partners to conduct a 6-month feasibility pilot of a tele-retinopathy screening intervention in a Community Health Centre in Ottawa. We anticipate recruiting 50-150 patients and 5-10 health care providers involved in delivering the intervention for the pilot. Acceptability will be assessed via a Theoretical Framework of Acceptability-informed survey with patients and health care providers. To assess feasibility, we will use a Theoretical Domains Framework-informed interview guide and to assess fidelity, and we will use a survey informed by the National Institutes of Health framework from the perspective of health care providers. We will also collect patient demographics (i.e., age, gender, ethnicity, health insurance status, and immigration information), screening outcomes (i.e., patients with retinopathy identified, patients requiring specialist care), patient costs, and other intervention-related variables such as preferred language. Survey data will be descriptively analyzed and qualitative data will undergo content analysis. DISCUSSION: This feasibility pilot study will capture how many people living with diabetes from each group attend the diabetic retinopathy screening, costs, and implementation processes for the tele-retinopathy screening intervention. The study will indicate the practicability and suitability of the intervention in increasing screening attendance in the target population groups. The study results will inform a patient-randomized trial, provide evidence to conduct an economic evaluation of the intervention, and optimize the community-based intervention.

Indexed as

AcceptabilityDiabetic retinopathyFeasibilityFidelityImmigrantsProtocolScreeningTele-retinopathyTheoretical domains frameworkTheoretical framework of acceptability

Identifiers

PMID37689724
PMCPMC10492373
OpenAlexW4386578989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.